Concepedia

Y. Sun

YS

Statistics

Publications

4

Citations

1K

H-Index

4

Active since

1994

Affiliations

Amgen (United States)(Current)

Y. Sun is an author at Amgen (United States) specializing in pharmacology, cancer immunotherapy, and cancer pharmacology.

Publications per year

1994–2014

4

Publications

4

Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor.

Babru Samal, Y. Sun, George Stearns et al. · Molecular and Cellular Biology · 1994 · 962 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +10

Preclinical development of<scp>AMG</scp>139, a human antibody specifically targeting<scp>IL</scp>‐23

Kathleen Köck, W. Pan, Jason M. Gow et al. · British Journal of Pharmacology · 2014 · 32 citations · Full text

Pharmacy, Immunology, Clinical Immunology +16

Safety and pharmacokinetics (PK) of AMG 706, panitumumab, and gemcitabine/cisplatin (GC) for the treatment of advanced solid malignancies

Jeffrey Crawford, Howard A. Burris, Mark N. Stein et al. · Journal of Clinical Oncology · 2006 · 11 citations

Medicine, Pharmacokinetics, Pharmacology +17

A randomized, placebo-controlled phase II study of AMG 386 plus bevacizumab (Bev) and paclitaxel (P) or AMG 386 plus P as first-line therapy in patients (pts) with HER2-negative, locally recurrent or metastatic breast cancer (LR/MBC).

Véronique Dièras, Jacek Jassem, Luc Dirix et al. · Journal of Clinical Oncology · 2011 · 10 citations

Medicine, Oncology, Pharmacology +17

1–4 of 4